Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
AI VIVO
AI VIVO helps drug developers predict how diseases and treatments affect organs to speed discovery of new medicines. It builds OrganoMaps by combining AI models with multi‑modal omics data and a…
AI VIVO
AI VIVO helps drug developers predict how diseases and treatments affect organs to speed discovery of new medicines. It builds OrganoMaps by combining AI models with multi‑modal omics data and a…
TL;DR
What they do: AI-driven organism-/organ-level pharmacology platform (OrganoMaps) for drug discovery
Customers: Pharmaceutical, biotechnology companies and research organizations (B2B)
HQ: Cambridge, United Kingdom
Stage / size: Early-stage; reported headcount 1–10
Known investor: O2h Ventures
Company Overview
Problem Domain
Drug discovery and translational pharmacology — modeling organ-level biology and treatment responses to prioritize targets and interventions.
Founded
2019
Industry
Biotechnology
Tech Stack
Funding Track Record
Listed as a support program in Dec 2020 (Dealroom)
Investor listed on public profiles
Investor Signal
“O2h Ventures listed as an investor”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week